WebMay 3, 2024 · A minority stake in what will become Haleon is owned by Pfizer, the American drugs behemoth. The new company is to be chaired by Sir Dave Lewis, the former Tesco chief executive. GSK and Haleon declined to comment. WebFeb 28, 2024 · At an update to investors today, GSK will announce that the proposed listing of Haleon (the newly independent company to be formed following the demerger of the GSK Consumer Healthcare business) is expected in July 2024, and will provide detail on the …
Haleon unveils brand-driven growth strategy ahead of GSK split
WebHaleon Jul 2024 - Present3 months Bengaluru, Karnataka, India Lead and responsible for Integration Strategy, Integration Architecture, Application … WebOct 5, 2024 · Haleon was formed from the consumer healthcare business of GSK, which held a 68% stake, and Pfizer, which held a 32% stake. The JV was formed with the intention of spinning off and listing Haleon within three years. Both GSK and Pfizer had been looking to offload their consumer businesses to focus on prescription medicines and vaccines. myheatshop.com
GSK completes split; Haleon launches as consumer health …
WebJul 25, 2024 · Earlier this year, GSK bought Sierra Oncology — a late-stage biopharmaceutical company based in San Mateo, California. The firm has a candidate drug for bone marrow cancer. It is projected that... WebAug 12, 2024 · Now the demerger has taken place, the total issued ordinary share capital of Haleon will mean that GSK shareholders will jointly own 54.5%, Pfizer will continue to hold 32%, GSK will hold 6% and 7.5% will be held by Scottish limited partnerships, which provide funding to GSK pensions. WebHaleon was established on 18 July 2024 as a corporate spin-off from GSK. Sir David Lewis is chairman, with Brian McNamara as CEO. Haleon is listed on the London Stock … my heat pump runs constantly